Biopreservation Market Size, Share & Growth | 2034

Biopreservation Market Overview

The global biopreservation market is experiencing substantial growth, driven by increasing demand for biobanking, regenerative medicine, and advanced cellular therapies. Biopreservation involves preserving biological samples, including cells, tissues, and organs, for research, clinical applications, and therapeutic use. The market is expanding due to technological advancements in cryopreservation techniques, storage solutions, and the growing adoption of personalized medicine. As healthcare institutions, research organizations, and pharmaceutical companies invest in biopreservation solutions, the market is poised for long-term growth. Government initiatives supporting biobanking projects and increasing R&D activities further contribute to the rising demand for biopreservation products and services.

Biopreservation Market Size

In 2024, the global biopreservation market was valued at approximately USD 6.4 billion, reflecting growing investments in biomedical research and cell-based therapies. With an anticipated compound annual growth rate (CAGR) of 14.4% between 2025 and 2034, the market is expected to reach USD 21.5 billion by 2034. The rising prevalence of chronic diseases, increasing organ transplantation procedures, and expanding use of regenerative medicine are key factors propelling market expansion. Furthermore, improvements in biopreservation techniques, such as controlled freezing and cryogenic storage, are enhancing the viability and longevity of biological materials, ensuring market sustainability.

Biopreservation Market Share

North America dominates the global biopreservation market, primarily due to the presence of major biotechnology firms, advanced healthcare infrastructure, and strong government support for life sciences research. The United States holds the largest market share, driven by extensive biobanking facilities and increased funding for cell-based therapies. Europe follows closely, benefiting from regulatory initiatives supporting regenerative medicine. Meanwhile, the Asia-Pacific region is witnessing rapid growth due to rising healthcare investments, increasing stem cell research, and expanding pharmaceutical manufacturing. Key players such as BioLife Solutions, Thermo Fisher Scientific, and MVE Biological Solutions are actively contributing to market growth through technological advancements and strategic partnerships.

Biopreservation Market Trends

• Advancements in Cryopreservation Techniques – Innovations in cryogenic storage and vitrification are improving sample viability and long-term storage capabilities.
• Growth in Regenerative Medicine Applications – Increasing use of stem cell therapies and tissue engineering is driving demand for biopreservation solutions.
• Expansion of Biobanking Facilities – Rising investments in biorepositories are enhancing the accessibility of biological samples for research and clinical use.
• Integration of AI and Automation – AI-driven sample tracking and automated storage solutions are improving efficiency and reliability in biopreservation.
• Increased Government and Private Funding – Funding initiatives for biomedical research and organ transplantation are fueling market expansion.
• Development of Eco-Friendly Storage Solutions – Companies are focusing on sustainable cryogenic storage methods to reduce environmental impact.

Biopreservation Market Analysis

The biopreservation market is evolving rapidly, with technological advancements and increasing applications in personalized medicine driving significant growth. Key factors influencing the market include:

• Technological Advancements: Enhanced freezing techniques and cryoprotectant solutions are improving sample preservation.
• Increasing Demand for Biobanking: Growth in stem cell research and personalized medicine is boosting biobanking activities.
• Rising Organ Transplantation Cases: Organ preservation solutions are gaining traction with the increasing number of transplant procedures.
• Challenges: High costs of cryopreservation systems, storage limitations, and regulatory complexities remain obstacles for market players.
• Opportunities: Emerging economies are investing in biopreservation technologies, creating new growth avenues for key industry players.

Biopreservation Market Segmentation

The biopreservation market is segmented based on product type, application, end-user, and region:

By Product Type:

• Biopreservation Media
• Biopreservation Equipment (Freezers, Refrigerators, Cryogenic Storage Systems)
• Lab Information Management Systems (LIMS)

By Application:

• Regenerative Medicine
• Biobanking
• Drug Discovery & Development
• Organ Transplantation

By End-User:

• Hospitals & Clinics
• Biobanks & Gene Banks
• Pharmaceutical & Biotechnology Companies
• Research Institutes

By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Biopreservation Market Growth

The biopreservation market is set for sustained growth, driven by the increasing adoption of regenerative medicine and expanding biobanking infrastructure. The demand for advanced cryopreservation techniques is rising as research institutions and biotech firms focus on long-term biological sample storage. The healthcare industry’s shift toward personalized medicine is also boosting the need for high-quality biopreservation solutions. Furthermore, increasing organ donation and transplantation procedures are enhancing market opportunities. Strategic collaborations between biotechnology companies and research organizations are accelerating innovation, ensuring steady market expansion over the next decade.

Get a Free Sample Report with a Table of Contents

Recent Developments and Challenges in the Biopreservation Market

Recent Developments:

• Advancements in cryopreservation techniques improving long-term sample viability.
• Expansion of biobanking facilities in emerging economies to support biomedical research.
• Integration of AI-powered storage management systems enhancing efficiency.
• Growing investment in sustainable and eco-friendly storage solutions.

Challenges:

• High Costs: Advanced cryopreservation systems require substantial financial investments.
• Storage Limitations: Limited cryogenic storage capacity poses challenges for biorepositories.
• Regulatory Compliance: Stringent guidelines for biobanking and biological material storage add complexity to market entry.
• Risk of Contamination: Maintaining sample integrity remains a crucial concern for industry players.

Key Players in the Biopreservation Market

BioLife Solutions, Inc. – A key provider of biopreservation media and cryopreservation solutions.

Thermo Fisher Scientific Inc. – Offers advanced biopreservation technologies for pharmaceutical and clinical applications.

Exact Sciences Corporation – Focuses on molecular diagnostics and biopreservation solutions for cancer research.

Simport Scientific Inc. – Specializes in laboratory consumables and cryogenic storage products.

ThermoGenesis Holdings, Inc. – Innovates in cellular processing and cryogenic storage solutions.

Lifeline Scientific – Provides organ preservation solutions and biopreservation equipment.

Princeton CryoTech – Develops cryogenic storage systems and liquid nitrogen-based preservation technologies.

MVE Biological Solutions – A leader in cryogenic storage and biobanking infrastructure.